538 related articles for article (PubMed ID: 29981834)
1. Erythropoietic regulators of iron metabolism.
Ganz T
Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
[TBL] [Abstract][Full Text] [Related]
2. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
Srole DN; Ganz T
J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
[TBL] [Abstract][Full Text] [Related]
3. Characterization of erythroferrone structural domains relevant to its iron-regulatory function.
Srole DN; Jung G; Waring AJ; Nemeth E; Ganz T
J Biol Chem; 2023 Dec; 299(12):105374. PubMed ID: 37866631
[TBL] [Abstract][Full Text] [Related]
4. Erythroid overproduction of erythroferrone causes iron overload and developmental abnormalities in mice.
Coffey R; Jung G; Olivera JD; Karin G; Pereira RC; Nemeth E; Ganz T
Blood; 2022 Jan; 139(3):439-451. PubMed ID: 34614145
[TBL] [Abstract][Full Text] [Related]
5. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
[TBL] [Abstract][Full Text] [Related]
6. Identification of erythroferrone as an erythroid regulator of iron metabolism.
Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T
Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340
[TBL] [Abstract][Full Text] [Related]
7. The BMP-SMAD pathway mediates the impaired hepatic iron metabolism associated with the ERFE-A260S variant.
Andolfo I; Rosato BE; Marra R; De Rosa G; Manna F; Gambale A; Iolascon A; Russo R
Am J Hematol; 2019 Nov; 94(11):1227-1235. PubMed ID: 31400017
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin.
Ganz T
Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
[TBL] [Abstract][Full Text] [Related]
9. Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
Kralova B; Sochorcova L; Song J; Jahoda O; Hlusickova Kapralova K; Prchal JT; Divoky V; Horvathova M
Am J Hematol; 2022 Oct; 97(10):1286-1299. PubMed ID: 35815815
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.
Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM
PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344
[TBL] [Abstract][Full Text] [Related]
11. Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia.
Olivera J; Zhang V; Nemeth E; Ganz T
Blood Adv; 2023 Jul; 7(14):3339-3349. PubMed ID: 36995275
[TBL] [Abstract][Full Text] [Related]
12. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
[TBL] [Abstract][Full Text] [Related]
13. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
[TBL] [Abstract][Full Text] [Related]
14. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders.
Wang C; Fang Z; Zhu Z; Liu J; Chen H
Exp Hematol; 2017 Aug; 52():24-31. PubMed ID: 28501597
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin and the BMP-SMAD pathway: An unexpected liaison.
Silvestri L; Nai A; Dulja A; Pagani A
Vitam Horm; 2019; 110():71-99. PubMed ID: 30798817
[TBL] [Abstract][Full Text] [Related]
17. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
18. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
19. A variant erythroferrone disrupts iron homeostasis in
Bondu S; Alary AS; Lefèvre C; Houy A; Jung G; Lefebvre T; Rombaut D; Boussaid I; Bousta A; Guillonneau F; Perrier P; Alsafadi S; Wassef M; Margueron R; Rousseau A; Droin N; Cagnard N; Kaltenbach S; Winter S; Kubasch AS; Bouscary D; Santini V; Toma A; Hunault M; Stamatoullas A; Gyan E; Cluzeau T; Platzbecker U; Adès L; Puy H; Stern MH; Karim Z; Mayeux P; Nemeth E; Park S; Ganz T; Kautz L; Kosmider O; Fontenay M
Sci Transl Med; 2019 Jul; 11(500):. PubMed ID: 31292266
[TBL] [Abstract][Full Text] [Related]
20. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.
Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
